Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neuropharmacology ; 39(13): 2654-62, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11044735

RESUMEN

The present study evaluated the interaction of lobeline with neuronal nicotinic acetylcholine receptors using two in vitro assays, [(3)H] overflow from [(3)H]dopamine ([(3)H]DA)-preloaded rat striatal slices and (86)Rb(+) efflux from rat thalamic synaptosomes. To assess agonist interactions, the effect of lobeline was determined and compared to S(-)-nicotine. To assess antagonist interactions, the ability of lobeline to inhibit the effect of S(-)-nicotine was determined. Both S(-)-nicotine (0.1-1 microM) and lobeline (>1.0 microM) evoked [(3)H] overflow from superfused [(3)H]DA-preloaded striatal slices. However, lobeline-evoked [(3)H] overflow is mecamylamine-insensitive, indicating that this response is not mediated by nicotinic receptors. Moreover, at concentrations (<1.0 microM) which did not evoke [(3)H] overflow, lobeline inhibited S(-)-nicotine (0.1-10 microM)-evoked [(3)H] overflow, shifting the S(-)-nicotine concentration-response curve to the right. S(-)-Nicotine (30 nM-300 microM) increased (EC(50) value=0.2 microM) (86)Rb(+) efflux from thalamic synaptosomes. In contrast, lobeline (1 nM-10 microM) did not evoke (86)Rb(+) efflux, and the lack of intrinsic activity indicates that lobeline is not an agonist at this nicotinic receptor subtype. Lobeline completely inhibited (IC(50) value=0.7 microM) (86)Rb(+) efflux evoked by 1 microM S(-)-nicotine, a concentration which maximally stimulated (86)Rb(+) efflux. Thus, the results of these in vitro experiments demonstrate that lobeline inhibits the effects of S(-)-nicotine, and suggest that lobeline acts as a nicotinic receptor antagonist.


Asunto(s)
Dopamina/metabolismo , Lobelina/farmacología , Neostriado/metabolismo , Nicotina/antagonistas & inhibidores , Agonistas Nicotínicos/farmacología , Receptores Nicotínicos/metabolismo , Sinaptosomas/metabolismo , Tálamo/metabolismo , Animales , Técnicas In Vitro , Masculino , Mecamilamina/farmacología , Neostriado/efectos de los fármacos , Nicotina/farmacología , Antagonistas Nicotínicos/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Nicotínicos/efectos de los fármacos , Radioisótopos de Rubidio , Estereoisomerismo , Sinaptosomas/efectos de los fármacos , Tálamo/efectos de los fármacos
2.
South Med J ; 91(4): 375-80, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9563432

RESUMEN

BACKGROUND: Frailty prevention and remedial programs based on exercise, hormone replacement, and vitamin supplementation are becoming available for use with older patients, but success of these programs depends largely on seniors' willingness to participate. METHODS: We evaluated preferences for specific aspects of these programs using a sample of 359 older persons recruited from potential delivery sites. Main effects and subgroup analyses were done. RESULTS: Subjects preferred stretching, chair-based, walking, and dynamic balance exercises over lifting weights, dancing, hormone and vitamin therapy; exercising alone in their own homes over exercising in groups; and vitamins over hormones. Preferences were affected to some extent by sex, race, recruitment site, and functional status. However, subjects' willingness even to consider exercise was rarely as high as the desired levels of participation set forth in Healthy People 2000. CONCLUSIONS: Physicians and public health authorities need to educate older persons about effective methods to prevent or treat frailty.


Asunto(s)
Actividades Cotidianas , Actitud Frente a la Salud , Promoción de la Salud , Accidentes por Caídas , Negro o Afroamericano/psicología , Anciano , Ejercicio Físico/psicología , Femenino , Anciano Frágil , Evaluación Geriátrica , Hormonas Esteroides Gonadales/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Vitaminas/uso terapéutico , Población Blanca/psicología
3.
Vet Pathol ; 32(5): 540-2, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-8578647

RESUMEN

Ocular contents from a horse with a 4-week history of severe unilateral uveitis were submitted for histopathologic examination. A severe unilateral granulomatous chorioretinitis with intralesional Halicephalobus deletrix was diagnosed. The horse developed progressive neurologic signs several days following the surgery to remove ocular contents and implant a prosthesis and was subsequently euthanatized. A severe multifocal granulomatous encephalitis with intralesional H. deletrix, localized primarily to the optic chiasm, thalamus, and brain stem, was diagnosed from tissues acquired at necropsy. The other eye was not affected. This is the first report of ocular parasitism by H. deletrix and suggests possible systemic dissemination from a primary site in the eye.


Asunto(s)
Coriorretinitis/veterinaria , Infecciones Parasitarias del Ojo/veterinaria , Enfermedades de los Caballos/patología , Infecciones por Rhabditida/veterinaria , Uveítis/veterinaria , Animales , Tronco Encefálico/patología , Coriorretinitis/parasitología , Coriorretinitis/patología , Encefalomielitis Equina/patología , Infecciones Parasitarias del Ojo/patología , Enfermedades de los Caballos/parasitología , Caballos , Masculino , Infecciones por Rhabditida/patología , Tálamo/patología , Uveítis/parasitología , Uveítis/patología
4.
Nature ; 343(6255): 282-4, 1990 Jan 18.
Artículo en Inglés | MEDLINE | ID: mdl-2300173

RESUMEN

Leukotrienes, the biologically active metabolites of arachidonic acid, have been implicated in a variety of inflammatory responses, including asthma, arthritis and psoriasis. Recently a compound, MK-886, has been described that blocks the synthesis of leukotrienes in intact activated leukocytes, but has little or no effect on enzymes involved in leukotriene synthesis, including 5-lipoxygenase, in cell-free systems. A membrane protein with a high affinity for MK-886 and possibly representing the cellular target for MK-886 has been isolated from rat and human leukocytes. Here, we report the isolation of a complementary DNA clone encoding the MK-886-binding protein. We also demonstrate that the expression of both the MK-886-binding protein and 5-lipoxygenase is necessary for leukotriene synthesis in intact cells. Because the MK-886-binding protein seems to play a part in activating this enzyme in cells, it is termed the five-lipoxygenase activating protein (FLAP).


Asunto(s)
Araquidonato 5-Lipooxigenasa/metabolismo , Araquidonato Lipooxigenasas/metabolismo , Proteínas Portadoras , Leucotrienos/biosíntesis , Proteínas de la Membrana/metabolismo , Proteínas Activadoras de la 5-Lipooxigenasa , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Línea Celular , Expresión Génica , Humanos , Proteínas de la Membrana/genética , Datos de Secuencia Molecular , Osteosarcoma , Ratas , Homología de Secuencia de Ácido Nucleico , Transfección
5.
Artículo en Inglés | MEDLINE | ID: mdl-2559412

RESUMEN

In a search for new inhibitors of leukotriene formation, a methylene chloride extract of the plant Dalbergia odorifera (Jiangxiang) was found to be a potent inhibitor of LTC4 formation in AB-CXBG Mct-1 mastocytoma cells. Following LH-20 and reverse phase HPLC chromatography, two compounds were isolated that had potent LTC4 inhibitory activity: medicarpin and 6-hydroxy-2-(2-hydroxy-4-methoxyphenyl) benzofuran (IV) with IC50s of 0.5 and 0.05 microM respectively. IV was shown to be a specific inhibitor of 5-lipoxygenase with an IC50 against the soluble rat enzyme of 0.08 microM, whereas it was inactive against cyclooxygenase. In neutrophils IV inhibited LTB4 production at comparable concentrations but had no effect on neutrophil degranulation or adhesion.


Asunto(s)
Antiinflamatorios no Esteroideos/aislamiento & purificación , Benzofuranos/aislamiento & purificación , Medicamentos Herbarios Chinos/aislamiento & purificación , Antagonistas de Leucotrieno , Plantas Medicinales/análisis , Pterocarpanos , Animales , Antiinflamatorios no Esteroideos/farmacología , Benzofuranos/farmacología , Benzopiranos/farmacología , Células Cultivadas , Cromatografía en Gel , Cromatografía Líquida de Alta Presión , Medicamentos Herbarios Chinos/farmacología , Femenino , Leucotrieno B4/biosíntesis , Inhibidores de la Lipooxigenasa , Ratones
6.
Ophthalmologica ; 189(1-2): 73-9, 1984.
Artículo en Inglés | MEDLINE | ID: mdl-6472810

RESUMEN

Abetalipoproteinemia (Bassen-Kornzweig syndrome, acanthocytosis) was diagnosed at age 13 months in a black male. At age 13 months, the electroretinogram was nonrecordable and a pigmentary retinopathy was obvious with ophthalmoscopy. Following dietary modification and vitamin supplementation, the scotopic electroretinogram improved to about 30% of normal.


Asunto(s)
Abetalipoproteinemia/diagnóstico , Retinitis Pigmentosa/diagnóstico , Preescolar , Diagnóstico Diferencial , Electrorretinografía , Angiografía con Fluoresceína , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Agudeza Visual
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA